CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 12,680
-490 (-3.72%)
At close: Jul 24, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 163.64 billion as of July 24, 2026. Its market cap has decreased by -49.93% in one year.
Market Cap
163.64B
Enterprise Value
151.73B
Revenue
2.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,680.00
ChartMarket Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 163.64B, a decrease of -37.79%. That is a compound annual growth rate of -23.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 163.64B | -45.96% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 268.39B |
| ImmuneOncia Therapeutics | 251.91B |
| NOVAREX | 219.84B |
| Cosmax Nbt | 160.33B |
| DAE HWA Pharmaceutical | 157.30B |
| Vivozon Pharmaceutical | 141.69B |
| GC WellBeing | 139.52B |
| Ahn-Gook Pharmaceutical | 133.32B |